ArticleInfection prevention in practice2025
Implementation of a peripheral intravenous catheter bundle to reduce phlebitis and hospital-onset
Article in Infection prevention in practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Peripheral intravenous catheters (PIVCs) are widely used in hospitals and account for up to one-third of hospital-onset Local Problem: In response to increasing HO-SAB, a quality improvement initiative was launched to reduce PIVC-related phlebitis and HO-SAB. Methods: An evidence-based bundle for peripheral intravenous catheter (PIVC) insertion and care was developed, focusing on four key components: hand hygiene, aseptic technique during insertion, daily monitoring and timely removal of PIVCs, and optimization of maintenance care. The bundle was piloted in two wards using the Model for Improvement, which led to a reduction in phlebitis rates. The same PIVC bundle was subsequently implemented in a phased manner across the hospital, with the implementation process guided by Kotter's 8-step model of change to ensure effective and sustainable adoption. Interventions: Interventions involved staff education, daily PIVC checks, process and outcome monitoring with feedback, ongoing ward engagement, and hospital-wide awareness campaigns. Key implementation measures included bundle compliance, phlebitis rates, and PIVC-related HO-SAB. Results: Phlebitis rates in pilot wards declined from 7% to 1-2%, with comparable reductions observed after hospital-wide implementation. PIVC-related HO-SAB rates decreased from 0.61 (pre-implementation) to 0.26 episodes per 10,000 patient-days. Conclusions: Overall, the structured care bundle significantly reduced phlebitis and was associated with lower PIVC-related HO-SAB rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.